International Journal of Medical Students (IJMS) Revenue and Competitors
Estimated Revenue & Valuation
- International Journal of Medical Students (IJMS)'s estimated annual revenue is currently $20.6M per year.
- International Journal of Medical Students (IJMS)'s estimated revenue per employee is $140,000
Employee Data
- International Journal of Medical Students (IJMS) has 147 Employees.
- International Journal of Medical Students (IJMS) grew their employee count by 32% last year.
International Journal of Medical Students (IJMS)'s People
Name | Title | Email/Phone |
---|
International Journal of Medical Students (IJMS) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.3M | 95 | 12% | N/A | N/A |
#2 | $20.6M | 147 | 32% | N/A | N/A |
#3 | $1.7M | 80 | 10% | N/A | N/A |
#4 | $2.1M | 15 | -21% | N/A | N/A |
What Is International Journal of Medical Students (IJMS)?
The International Journal of Medical Students (IJMS) is an online peer-reviewed open-access scientific journal (ISSN 2076-6327), created to share the scientific production and experiences of medical students worldwide. Our objective is to be the primary diffusion organ for medical students, using standards that accredit the process of scientific publication. The impact factor for the IJMS is 5.62 according to the Index Copernicus (ICV 2012), 3.034 according to the Scientific Journal Impact Factor (SJIF), 1.212 according to the International Impact Factor Services, and 40.16 according to InfoBase Index. This makes the IJMS the number one ranked journal for medical students.
keywords:N/AN/A
Total Funding
147
Number of Employees
$20.6M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.2M | 147 | 6% | N/A |
#2 | $7.5M | 147 | 4% | N/A |
#3 | $23.6M | 148 | 20% | N/A |
#4 | $22.3M | 148 | 0% | $24.6M |
#5 | $23.6M | 148 | -7% | N/A |